337 related articles for article (PubMed ID: 16373409)
1. Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles.
Mochtar MH; Van Wely M; Van der Veen F
Hum Reprod; 2006 Apr; 21(4):905-8. PubMed ID: 16373409
[TBL] [Abstract][Full Text] [Related]
2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
3. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
4. Effects of early luteal-phase vaginal progesterone supplementation on the outcome of in vitro fertilization and embryo transfer.
Mui Lam P; Chun Cheung M; Ping Cheung L; Ingrid Lok H; John Haines C
Gynecol Endocrinol; 2008 Dec; 24(12):674-80. PubMed ID: 19172535
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
[TBL] [Abstract][Full Text] [Related]
6. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists.
Kolibianakis EM; Schultze-Mosgau A; Schroer A; van Steirteghem A; Devroey P; Diedrich K; Griesinger G
Hum Reprod; 2005 Oct; 20(10):2887-92. PubMed ID: 15979994
[TBL] [Abstract][Full Text] [Related]
7. Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer.
Mitwally MF; Diamond MP; Abuzeid M
Fertil Steril; 2010 Feb; 93(2):554-69. PubMed ID: 19362305
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phase support.
Ludwig M; Finas A; Katalinic A; Strik D; Kowalcek I; Schwartz P; Felberbaum R; Küpker W; Schöpper B; Al-Hasani S; Diedrich K
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):574-82. PubMed ID: 11380297
[TBL] [Abstract][Full Text] [Related]
10. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of Qublan H; Amarin Z; Al-Qudah M; Diab F; Nawasreh M; Malkawi S; Balawneh M
Hum Fertil (Camb); 2008 Mar; 11(1):43-7. PubMed ID: 18320439
[TBL] [Abstract][Full Text] [Related]
11. Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial.
Unfer V; Casini ML; Gerli S; Costabile L; Mignosa M; Di Renzo GC
Fertil Steril; 2004 Dec; 82(6):1509-13. PubMed ID: 15589851
[TBL] [Abstract][Full Text] [Related]
12. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
13. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles.
Kyrou D; Fatemi HM; Popovic-Todorovic B; Van den Abbeel E; Camus M; Devroey P
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):175-9. PubMed ID: 20219279
[TBL] [Abstract][Full Text] [Related]
14. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
15. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
Pirard C; Donnez J; Loumaye E
Hum Reprod; 2005 Jul; 20(7):1798-804. PubMed ID: 15890740
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
18. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
[TBL] [Abstract][Full Text] [Related]
19. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort.
Moffitt DV; Queenan JT; Shaw R; Muasher SJ
Fertil Steril; 1997 Feb; 67(2):296-301. PubMed ID: 9022606
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist.
Var T; Tonguc E; Dogan M; Mollamahmutoglu L
Gynecol Endocrinol; 2011 Aug; 27(8):558-61. PubMed ID: 20642381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
